Chester County News and Community Website
MyChesCo is the perfect source for businesses in Philadelphia to stay informed and up-to-date with the latest business news. We provide essential information to help businesses grow, network, and hire. Our content is concise and objective, making it easy to stay informed and make well-informed decisions.
MyChesCo provides comprehensive Philadelphia business news, giving you the latest information and updates about local businesses. Our content features news about upcoming events, articles, and resources to help businesses grow and expand. We provide in-depth coverage of relevant topics and trends in the local business community, making it easy to stay informed and up-to-date.
MyChesCo also features resources to help businesses network and hire. Our content focuses on helping businesses connect with each other and build relationships. We also provide resources to help businesses find new hires and fill job openings. We make it easy for Philadelphia businesses to network and find the best talent to move their businesses forward.
Our content is comprehensive and accessible, making it easy for businesses in Philadelphia to find the information they need. Our content is updated regularly, giving you the most up-to-date news and information about local businesses. We provide concise and objective content, making it easy to stay informed and make well-informed decisions about your business.
PHILADELPHIA, PA — Phenom recently released a hiring automation benchmark report showing most employers still rely on delayed post-application screening processes despite increasing investment in artificial intelligence tools designed to …
Employers Lag on Hiring Automation as Vacancies Drag On Read More
PHILADELPHIA, PA — Onbe has appointed Melissa Hentschel as chief executive officer and added her to the company’s board, positioning a longtime payments executive to lead the fintech as businesses …
Onbe Names Melissa Hentschel CEO as Payouts Shift Accelerates Read More
PHILADELPHIA, PA — Aramark (NYSE: ARMK) declared a quarterly cash dividend of $0.12 per share as the company continues operating across education, healthcare, sports and corporate services markets globally.
Aramark Declares Quarterly Dividend Amid Services Expansion Read More
PHILADELPHIA, PA — True launched a dedicated longevity-focused executive search practice aimed at companies operating at the intersection of healthcare, life sciences and consumer wellness, as investment in healthspan-related technologies …
True Launches Longevity Practice as Healthspan Market Expands Read More
PHILADELPHIA, PA — Yellowwood Technologies launched an AI-driven workflow platform aimed at helping investment firms standardize how they evaluate direct investment opportunities, as private-market investors increasingly seek automated tools to …
Yellowwood Launches AI Platform for Private Deal Review Read More PHILADELPHIA, PA — Phenom announced it achieved FedRAMP Ready status, positioning the company to offer artificial intelligence-driven hiring and workforce management tools to U.S. government agencies operating under federal security …
Phenom Secures FedRAMP Status for Government Hiring Push Read More
PHILADELPHIA, PA — Gregory has received Gold recognition in the PR Agency category of The Philadelphia Inquirer’s 2026 Philly Favorites awards, adding a local distinction to a recent series of …
Gregory Expands Industry Momentum With Philadelphia PR Award Read More
PHILADELPHIA, PA — RISR recently launched an artificial intelligence-powered document analysis platform aimed at helping financial advisors identify legal and financial risks for business owners as trillions of dollars in …
RISR Launches AI Tool for Business Owner Risk Reviews Read More PHILADELPHIA, PA — CTIBIOTECH launched its North American subsidiary in Philadelphia as part of a planned U.S. expansion backed by nearly $27 million in operational and intellectual property investments aimed …
CTIBIOTECH Expands to Philadelphia in U.S. Growth Push Read More
PHILADELPHIA, PA — Lannett Company announced that the U.S. Food and Drug Administration approved LANGLARA, an interchangeable biosimilar to Lantus insulin, expanding the number of lower-cost insulin treatment options available …
FDA Approves Interchangeable Lantus Biosimilar for Diabetes Read More